Active Learning via Incremental Revelation: Dipeptidyl Peptidase-4 Inhibitors Case Study
Please click here to check the detail.
- TOP
- View All
- Case Studies
- Active Learning via Incremental Revelation: Dipeptidyl Peptidase-4 Inhibitors Case Study
Thank you for your interest in Elix. If you have any inquiries about our AI drug discovery platform or conducting joint research, or if you would like to conduct an interview with us, please click the Contact button on the right to get in touch with us.
We will respond as soon as possible.